Why the study?
Mean platelet volume indicates platelet reactivity and could serve as a biomarker of risk and prognosis in STEMI, prompting evaluation of its predictive value for thrombus burden and short-term outcomes.
Does higher mean platelet volume on admission predict higher angiographic thrombus burden and worse short-term outcomes in patients with STEMI undergoing primary PCI?
Comparison
MPV measured on admission across thrombus burden and outcome categories
Follow-up
3 to 6 months
Loading...
MPV may identify higher-risk STEMI patients; leaves open whether it adds value to existing risk models.
Does higher mean platelet volume on admission predict higher angiographic thrombus burden and worse short-term outcomes in patients with STEMI undergoing primary PCI?
Higher mean platelet volume on admission in STEMI patients undergoing primary PCI is associated with greater angiographic thrombus burden, worse myocardial perfusion, and poorer short-term clinical outcomes.
A 2024 study studied this question.